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The DNA-dependent protein kinase (DNA-PK) plays an essential role in nonhomologous DNA end joining
(NHEJ) by initially recognizing and binding to DNA breaks. We have shown that in vitro, purified DNA-PK
undergoes autophosphorylation, resulting in loss of activity and disassembly of the kinase complex. Thus, we
have suggested that autophosphorylation of the DNA-PK catalytic subunit (DNA-PKcs) may be critical for
subsequent steps in DNA repair. Recently, we defined seven autophosphorylation sites within DNA-PKcs. Six
of these are tightly clustered within 38 residues of the 4,127-residue protein. Here, we show that while
phosphorylation at any single site within the major cluster is not critical for DNA-PK’s function in vivo,
mutation of several sites abolishes the ability of DNA-PK to function in NHEJ. This is not due to general
defects in DNA-PK activity, as studies of the mutant protein indicate that its kinase activity and ability to form
a complex with DNA-bound Ku remain largely unchanged. However, analysis of rare coding joints and ends
demonstrates that nucleolytic end processing is dramatically reduced in joints mediated by the mutant
DNA-PKcs. We therefore suggest that autophosphorylation within the major cluster mediates a conformational
change in the DNA-PK complex that is critical for DNA end processing. However, autophosphorylation at these
sites may not be sufficient for kinase disassembly.
Although DNA is the genetic blueprint for all living organ-
isms, it is extremely sensitive to various forms of damage,
including oxidation, hydrolysis, and methylation. Thus, efficient
DNA repair systems are essential for the maintenance of chro-
mosomal integrity. DNA double-strand breaks (DSBs) are per-
haps the most lethal form of DNA damage. In eukaryotes,
primarily two pathways repair DSBs: homologous recombina-
tion and nonhomologous DNA end joining (NHEJ). In higher
eukaryotes, NHEJ is thought to be the major pathway that
repairs these breaks (6, 29, 37, 38). Because NHEJ also func-
tions in developing lymphocytes to repair the DSBs introduced
during antigen receptor gene rearrangement, defects in this
pathway result in a block in lymphocyte development and the
disease known as severe combined immunodeficiency (SCID)
(reviewed in references 14 and 29).
In the past decade, an intensive research effort has focused
on NHEJ, resulting in a reasonable understanding of how
DSBs are resolved. There are six known factors which unequiv-
ocally function in the NHEJ pathway. Three of these comprise
the DNA-dependent protein kinase (DNA-PK) (reviewed in
references 19, 20, and 25): the two subunits of the DNA end
binding heterodimer Ku and the catalytic subunit of DNA-PK
(DNA-PKcs) (18). Two other factors, XRCC4 and DNA ligase
IV, form a stable DNA ligase complex (15, 28, 34). The sixth
factor, Artemis, was described in 2001 (35); recent data indi-
cate that it may play an important role in DNA end processing
during NHEJ (31).
DNA-PK plays a central role in NHEJ because it initially
recognizes and binds to damaged DNA and then targets other
repair activities to the site of damage. The first step in NHEJ
is binding of the Ku70/86 heterodimer to DNA ends at the site
of DNA damage. When bound, Ku encircles the DNA. The Ku
binding site covers approximately two turns of the DNA helix,
but only the central 3 to 4 bp are completely encircled by the
polypeptide chain. The DNA terminus is cupped in an acces-
sible binding pocket (46), theoretically allowing DNA-PKcs to
interact directly with the DNA end. Recruitment of DNA-
PKcs results in translocation of Ku to internal sites of the
linear DNA (51). When assembled onto DNA ends, DNA-PK
is activated; it can then phosphorylate a variety of substrates
including both Ku subunits, DNA-PKcs, XRCC4, and Artemis
(4, 5, 8, 24, 31). Recent data from our laboratory and others
demonstrate that the protein kinase activity of DNA-PK is
essential during NHEJ (1, 21, 22), suggesting that phosphory-
lation by DNA-PK activates a downstream factor in the path-
way.
In assay systems utilizing purified proteins, autophosphory-
lation of DNA-PK results in the release of DNA-PKcs from
DNA-bound Ku and a decrease in the measurable protein
kinase activity (4, 5, 8, 33). We suggest a model whereby au-
tophosphorylation of DNA-PKcs and the resulting remodeling
and/or disassembly of the DNA-PK complex could facilitate
subsequent steps in the DNA repair process. To test this
model, we have generated point mutations of the six clustered
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autophosphorylation sites previously mapped within DNA-
PKcs (9). We find that phosphorylation of any single site is not
critical to DNA-PK’s function; however, mutation of several
phosphorylation sites abolishes the ability of DNA-PK to func-
tion in NHEJ. Finally, both in vivo and in vitro studies of the
mutant protein suggest that autophosphorylation at the major
cluster specifically facilitates DNA end processing, whereas
further autophosphorylation is required to promote kinase dis-
assembly.
MATERIALS AND METHODS
Cell lines and culture conditions. The DNA-PKcs-deficient DSB repair mu-
tant CHO cell line V3 (47) was the generous gift of Martin Gellert. Cells were
maintained in -MEM with 10% fetal calf serum (Gibco BRL, Gaithersburg,
Md.). Stable transfectants were maintained with 400 g of G418/ml.
Oligonucleotides. Oligonucleotides used in this study are as follows (5 to 3).
The two oligonucleotides flanking the phosphorylation site cluster were KAM97
(GATGTGCTGATTCAAGGATTGA) and KAM98 (ATAAACCGTCTGCGC
AGTCGT).
Mutagenic oligonucleotides (complements not shown) were KAM99 (mutant
A) (TTTGTGGAGGCTCAGGCCTCC), KAM101 (mutant B) (GTGCTCAGG
AAGGGGCTCTCTCA), KAM103 (mutant C) (ATAAGGGCCGCTCAGCAG
CAG), KAM105 (mutant D) (TTCACACTGGCCCAGACTGCA), KAM132
(mutant CD) (CCGCTCAGCAGCAGCATGACTTCACACTGGCCCAGACT),
KAM146 (mutant E) (CAGGCCGCTCAGGGCACTCTCCAGACC), and KAM
165 (S3D, mutant ABCDE) (AGGATCAGGCCGATCAGGGCACTCTCCAGA
CCCGTGATCAGGAAGGGGATCTCTCAGCTCGCTGGCCAGTGGCAGGG
CAGATAAGGGCCGATCAGCAGCAGCATGACTTCACACTGGATCAGA
CT). Positions at which serine or threonine was changed to alanine or aspartic acid
are shown in boldface.
Oligonucleotides used in ligation-mediated PCR (LMPCR) were KAM150
(LMPCR ligation oligonucleotide, blunt ends, top strand) (GCTATGTACTAC
CCGGGAATTCGTG), KAM201 (LMPCR ligation oligonucleotide, 3 over-
hang ends, top strand) (GCTATGTACTACCCGGGAATTCGTGCCGG),
KAM200 (LMPCR ligation oligonucleotide, bottom strand) (CACGAATTC
CC), KAM214 (LMPCR primer, linker outer) (GCTATGTACTACCCGGGA
AT), KAM216 (LMPCR primer, linker inner signal ends) (GGGAATTCGTG
CACAGTG), KAM206 (LMPCR primer, linker inner 3 overhang coding ends)
(GGGAATTCGTGCCGGATC), KAM218 (LMPCR primer, CAT, outer) (AT
ATCCAGCTGAACGGTCTG), KAM219 (LMPCR primer, CAT, inner) (GT
TATAGGTACATTGAGCAAC), KAM217 (LMPCR primer, oop, outer) (GA
CCCCCCATTCAAGAACAGC), KAM215 (LMPCR primer, oop, inner) (GC
AGCATTGAGAACTTTGG), and KAM88 (LMPCR hybridization probe) (CC
AGTGATTTTTTTCTCCATTTTAG).
Oligonucleotides used in the electrophoretic mobility shift assay (EMSA) were
DAR166 (CAGCTGGGAATTCCATATGAGTACTGCAGATGCACTTGCT
CGATAGATCTAACATGAGCC) and DAR167 (GTAGGGCTCATGTTAGA
TCTATCGAGCAAGTGCATCTGCAGTACTCATATGGAATTCCCAGCT
GAG).
Construction and transfection of expression plasmids. Construction of the
wild-type human DNA-PKcs expression vector has been described previously
(43) and was accomplished by assembling the following three fragments spanning
the DNA-PKcs coding sequence from eight shorter reverse transcription-PCR
fragments isolated from the Ramos human B-cell lymphoma cell line: 1-3860,
3559-8173, and 7911-12358. To generate expression plasmids encoding phos-
phorylation site mutants, duplex oligonucleotides encoding each mutation were
utilized in PCR using single-strand overlap extension as described previously (21)
in conjunction with oligonucleotides KAM97 and KAM98. The resulting PCR
fragment was cloned by using the Topo TA cloning kit according to the manu-
facturer’s protocol (Invitrogen, Carlsbad, Calif.). This PCR fragment spans
unique AgeI and FseI sites at positions 7620 and 8166 in the open reading frame
of the human DNA-PKcs cDNA. It was subsequently subcloned into the wild-
type DNA-PKcs expression vector. There is an additional AgeI site within the
vector sequence. To prepare the vector for ligations, partial AgeI digests were
performed with a limiting enzyme, or in some experiments, partial digestion was
achieved by protecting the vector site (from AgeI digestion) by treating the DNA
with a complementary oligonucleotide and recombinant RecA protein. For cer-
tain multiple phosphorylation site mutants, the QuikChange mutagenesis kit
(Stratagene, La Jolla, Calif.) was utilized to introduce mutations into the sub-
cloned PCR fragment spanning the FseI and AgeI sites. Mutant expression
constructs were confirmed by sequence analysis of the entire FseI-AgeI fragment
after it was cloned back into the complete DNA-PKcs expression construct.
V3 transfectants expressing human DNA-PKcs were derived by stably trans-
fecting cells with 40 g of a PvuI-linearized expression plasmid and 1 g of a
NotI-linearized pcDNAI/Neo plasmid (Invitrogen). Transfections were per-
formed in 60-mm-diameter dishes by using the FuGENE 6 transfection reagent
(Roche Molecular Biochemicals, Indianapolis, Ind.) according to the manufac-
turer’s instructions. Forty-eight hours after transfection, cells were placed under
selection conditions (400 g of G418/ml) and isolated clones were obtained.
Individual colonies were screened for DNA-PKcs expression by immunoblot
analysis and were further cultured.
Immunoblot analysis. The indicated amounts of whole-cell extracts were an-
alyzed after electrophoresis on a sodium dodecyl sulfate (SDS)–5% polyacryl-
amide gel and transfer to a polyvinylidene difluoride membrane. A monoclonal
antibody raised against DNA-PKcs (42-27; a generous gift of Tim Carter, St.
John’s University, New York, N.Y.) was used as the primary antibody (dilution,
1:300). A goat anti-mouse immunoglobulin G conjugated to horseradish perox-
idase was used as the secondary antibody. The membrane was then incubated
with a chemiluminescent substrate (ECL; DuPont) according to the manufac-
turer’s recommendations.
Assessment of radiation sensitivity. Cells (3  103) were exposed to various
amounts of ionizing radiation using a 60Co source and immediately seeded in
complete medium containing 10% fetal bovine serum. After 7 days, cell colonies
were fixed with ethanol and stained with crystal violet, and colony numbers were
assessed.
V(D)J recombination assay. Extrachromosomal recombination assays were
performed essentially as described previously (21). To assess V(D)J recombina-
tion in V3 cells, RAG-1 and RAG-2 expression constructs (3 g each), expres-
sion plasmids encoding DNA-PKcs, or the pCMV6 vector control (6 g) and a
recombination substrate (pJH201 or pJH290; 1 g) were transfected by liposome
using the FuGENE 6 transfection reagent (Roche Molecular Biochemicals). In
some experiments, 6 g of a terminal deoxynucleotidyl transferase (Tdt) expres-
sion plasmid was included in the transfections. Forty-eight hours later, plasmid
substrates were rescued from the cells by alkaline lysis. Alkaline lysates were
restricted with DpnI and then used to transform chemically competent Esche-
richia coli. Transformed bacteria were spread onto two Luria-Bertani agar plates,
one containing 100 g of ampicillin/ml and the other containing 100 g of
ampicillin/ml plus 22 g of chloramphenicol/ml. For sequence analyses, plasmid
DNA was prepared from individual chloramphenicol-resistant colonies. Se-
quencing was performed by the Michigan State University sequencing facility.
DNA cellulose pulldown of DNA-PK and measurement of protein kinase
activity. Whole-cell extracts were prepared by a modification of the method of
Finnie et al. (11). Briefly, 20  106 cells were harvested and washed three times
in phosphate-buffered saline, and cell pellets were frozen at 80°C. Frozen cell
pellets were resuspended in 20 l of extraction buffer (20 mM HEPES [pH 7.8],
450 mM NaCl, 50 mM NaF, 25% [vol/vol] glycerol, 0.2 mM EDTA) with Com-
plete protease inhibitor (EDTA free; Roche Molecular Biochemicals). The re-
suspended pellets were then subjected to three freeze-thaw cycles (liquid nitro-
gen; 37°C) and centrifuged at 8,160  g for 7 min at 4°C. Supernatants were
stored at 80°C prior to use, and concentrations were determined by Bradford
analysis using bovine serum albumin as a standard.
The SignaTECT DNA-PK assay system (Promega Corp., Madison, Wis.) was
used to assay DNA-PK activity with the following modifications. Whole-cell
extracts (amounts indicated in each figure legend) were incubated with 20 l of
preswollen double-stranded DNA-cellulose beads (Amersham Pharmacia Bio-
tech) for 30 min at 4°C. The double-stranded DNA-cellulose was then washed
three times with 1 ml of buffer A (25 mM HEPES [pH 7.9], 50 mM KCl, 10 mM
MgCl2, 10% [vol/vol] glycerol, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol
[DTT]). To measure protein kinase activity, the DNA-cellulose was resuspended
in 20 l of a DNA-PK reaction buffer containing 100 g of bovine serum
albumin/ml. Protein kinase reactions were conducted with 10-l aliquots of the
resuspended cellulose beads and were performed both in the presence and in the
absence of a biotinylated p53-derived substrate peptide and [-32P]ATP. Reac-
tions were terminated and analyzed after spotting onto a SAM2 membrane,
washing, and counting in a scintillation counter according to the manufacturer’s
instructions (Promega Corp., Madison, Wis.). All assays were performed in
duplicate with at least three different extract preparations. In some assays,
recombinant XRCC4 or Artemis was utilized as a substrate instead of the p53
peptide. Ni-agarose purification of these proteins was performed as described
previously (24). In these experiments, phosphorylation was assessed by autora-
diography of SDS-polyacrylamide gel electrophoresis (PAGE) gels.
Assessment of autophosphorylation. To assess autophosphorylation, 1 mg of
whole-cell extracts was absorbed onto 20 l of DNA-cellulose for 30 min on ice
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and then washed three times in buffer A. DNA-cellulose fractions were incu-
bated in buffer A with [-32P]ATP for 15 min at room temperature and then
analyzed by SDS-PAGE and autoradiography.
Purification of recombinant DNA-PKcs. The purified recombinant human Ku
heterodimer was generated as previously described (36). Purified human DNA-
PKcs was obtained from 5 liters of V3 cells stably transformed with either
wild-type or ABCDE mutant DNA-PKcs. The washed cell pellet was extracted by
homogenization in 50 ml of a buffer containing 50 mM Tris-HCl (pH 7.5), 600
mM KCl, 10% glycerol, 1 mM DTT, 5 mM EDTA, and 0.5 ml of a protease
inhibitor cocktail (P8340; Sigma) and was clarified by centrifugation at 60,000 
g for 1 h. Nucleic acids were depleted by stirring the extract for 15 min with 5 ml
of a 70% slurry of polyethyleneimine-cellulose (Sigma). Polyethyleneimine-cel-
lulose with absorbed nucleic acid was removed by filtration. The filtrate was than
dialyzed to buffer A (25 mM HEPES-KOH [pH 7.5], 10% glycerol, 1 mM DTT,
0.1 mM EDTA) plus 50 mM KCl (see Fig. 3A, lane 1) and loaded onto an affinity
column (80peptide) generated by coupling 5 mg of a peptide from the C terminus
of Ku80 (KGSGEEGGDVDDLLDMI; derived from the work of Gell and Jack-
son [13]) to a 1-ml, N-hydroxysuccinimide-activated HiTrap column (Amersham
Biosciences). Bound proteins were eluted by a gradient to buffer A plus 1 M KCl.
DNA-PKcs-containing fractions were identified by SDS-PAGE analysis, pooled
(Fig. 3A, lane 3), and dialyzed against buffer A plus 100 mM KCl. The dialysate
was then loaded onto a 100-l Mono S ion-exchange column (Amersham Bio-
sciences) and eluted with a 2-ml gradient to buffer A plus 350 mM KCl (Fig. 3A,
lane 5). Ion-exchange chromatography both removed the remaining major con-
taminant (180-kDa band in Fig. 3A, lanes 3 and 4) and concentrated the
protein 25-fold. Fractions were flash-frozen in liquid nitrogen in small aliquots.
Assays using purified proteins. The kinase activity of purified DNA-PKcs was
assessed in a buffer containing 50 mM HEPES-KOH (pH 7.5), 150 mM NaCl, 0.1
mM EDTA, and 0.2 mM EGTA. The peptide substrate used was biotin-
EPPLSQEAFADLWKK. Phosphorylation of the peptide was assessed as de-
scribed previously (7). For EMSA analysis, we used a 60-bp double-stranded
DNA substrate made by annealing the 5 32P-labeled oligonucleotide DAR166
(defined above) to DAR167. One hundred nanomolar DNA-PKcs stocks were
inactivated by treatment with 10 M wortmannin or mock treated with an
equivalent amount of a solvent (dimethyl sulfoxide) for 10 min on ice prior to
dilution into the reaction mixture. Samples were prepared for EMSA analysis in
two steps. In the first step (complex assembly and autophosphorylation), DNA-
protein complexes were formed with 10 nM each protein and 100 nM duplex
DNA by using a buffer containing 25 mM Tris-HCl (pH 8.0) supplemented with
5 mM MgCl2 and 200 M ATP. Reaction mixtures were incubated for 10 min at
30°C before autophosphorylation was arrested by addition of 5 mM EDTA. In
the second step (probing the stability of complexes), reaction products were
adjusted with added NaCl to the indicated salt concentrations and were incu-
bated for a further 10 min at room temperature. Stable DNA-protein complexes
were then fixed by cross-linking using 0.25% glutaraldehyde and were resolved by
electrophoresis on a 3.5% native PAGE gel in 1 Tris-borate-EDTA at 18 V/cm.
The composition of each indicated species was confirmed by antibody supershift
analysis (data not shown).
Construction of an Artemis-expressing baculovirus and coimmunoprecipita-
tion. A cDNA encoding full-length human Artemis was assembled from over-
lapping reverse transcription-PCR fragments. Although numerous splice variants
were isolated, we assembled a full-length coding sequence analogous to that
shown previously to complement the V(D)J recombination deficit in Artemis-
deficient cell lines (35). The termination codon was not included, and an in-
frame 3 V5-His tag was added at the C terminus. The assembled fusion protein
construct was subcloned into the pAcHCT-C transfer vector (Pharmingen, San
Diego, Calif.). A recombinant baculovirus encoding human Artemis was ob-
tained by using Baculogold-linearized viral DNA (Pharmingen) and standard
techniques. For the pulldown experiments for which results are shown in Fig. 5,
whole-cell extracts of V3 transfectants (1 mg) and whole-cell extracts from either
Artemis-infected or control Sf9 cells were coincubated for 30 min. Subsequently,
50 l of Ni agarose was added, and the extracts were absorbed in buffer A with
25 mM imidazole. After 1 h, the Ni agarose was washed three times with buffer
A containing 50 mM imidazole. Proteins were eluted with SDS-PAGE buffer and
analyzed by immunoblotting.
Analyses of V(D)J recombination intermediates. V3 cells were transfected
either with the pJH290 recombination substrate alone, with the substrate and the
RAG expression plasmids, or with the substrate and the RAG and DNA-PKcs
expression plasmids as described above. Hirt supernatants were prepared from
transfected cells as follows. Forty-eight hours after transfection, cells were har-
vested, resuspended in 400 l of Hirt buffer 1 (10 mM Tris [pH 8.0], 1 mM
EDTA, 0.6% SDS), and incubated for 15 min at room temperature. One hun-
dred microliters of Hirt buffer 2 (10 mM Tris [pH 8.0], 1 mM EDTA, 5 M NaCl)
was added, and the samples were incubated overnight at 4°C. After being spun
for 10 min at 10,000  g at 4°C, supernatants were extracted with phenol-
chloroform, ethanol precipitated, and then resuspended in 10 l of double-
distilled water. Five microliters of each Hirt supernatant was ligated to 500 pmol
of annealed oligonucleotides KAM150–KAM200 or KAM201–KAM200 at 16°C
overnight. Ligated Hirt supernatants were ethanol precipitated and used in
nested PCR amplifications. Signal ends were amplified first with the primer
combination KAM214–KAM217 and then with KAM216–KAM215. Coding
ends were amplified first with the primer combination KAM214–KAM218 and
then with KAM206–KAM219. Forty cycles of amplification were performed
using the following conditions: for primary PCRs, 94°C for 30 s, 58°C for 1 min,
and 68°C for 1 min; for secondary PCRs, 94°C for 30 s, 56°C for 1 min, and 68°C
for 1 min). Amplification products were analyzed by Southern hybridization
using oligonucleotide KAM88 as a hybridization probe.
RESULTS
Six of seven autophosphorylation sites are located within a
38-amino-acid cluster within human DNA-PKcs. Recently, the
locations of seven in vitro autophosphorylation sites within
DNA-PKcs were reported (9). As diagrammed in Fig. 1A, six
of the seven phosphorylation sites are tightly clustered in a
short region of primary sequence in the central region of the
molecule (amino acids 2609 to 2647). Four of the six clustered
autophosphorylation sites (T2609, S2612, T2638, and T2647)
are also phosphorylated in vivo in okadaic acid-treated cells.
All four of these in vivo sites are completely conserved among
the six sequenced vertebrate DNA-PKcs genes (human, horse,
dog, mouse, chicken, and frog).
To begin to assess the functional relevance of autophosphor-
ylation of DNA-PKcs, several point mutations of the DNA-
PKcs cDNA were generated. Initially, five mutant constructs,
designated A, B, C, D, and E, were generated, as indicated in
Fig. 1A. Constructs A, C, D, and E each contain a single
mutation of serine or threonine to alanine, as indicated. Mu-
tation B includes two mutations of serine or threonine to
FIG. 1. Single phosphorylation site mutants complement the radiosensitivity of V3 cells, whereas multiple phosphorylation site mutants do not.
(A) Diagrammatic representation of seven autophosphorylation sites within DNA-PKcs (asterisks). Mutations are as follows: A, T2609A; B,
T2620A and S2624A; C, T2638A; D, T2647A; E, S2612A. The A, B, C, D, and E mutations were introduced either alone or in combinations as
indicated. (B) Immunoblot analyses of whole-cell extracts from V3 transfectants expressing either full-length DNA-PKcs (lane 1), vector alone
(lane 2), mutant A (lane 3), mutant B (lane 4), mutant C (lane 5), mutant D (lane 6), or mutant E (lane 7). (C) The radiation resistance of V3
transfectants expressing wild-type DNA-PKcs, vector alone, or each of the single phosphorylation site mutants was assessed as described in
Materials and Methods. Data are presented as percent survival relative to that of nonirradiated controls (set at 100%). Error bars, standard errors
of the means of three separate experiments. (D) Immunoblot analyses of whole-cell extracts from V3 transfectants expressing either full-length
DNA-PKcs (lane 1), vector alone (lane 2), mutant AB (lane 3), mutant AC (lane 4), mutant AD (lane 5), mutant ABCD (lane 6), or mutant
ABCDE (lane 7). (E) The radiation resistance of V3 transfectants expressing either wild-type DNA-PKcs, vector alone, or mutant AB, AC, AD,
ABCD, or ABCDE was assessed. Data are presented as percent survival relative to that of nonirradiated controls (set at 100%). Error bars,
standard errors of the means of three separate experiments.
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alanine (T2620 and S2624); to date, phosphorylation of these
two sites has been observed in vitro but not in vivo.
Single phosphorylation site mutant constructs complement
V3’s radiosensitivity similarly to constructs encoding wild-type
DNA-PKcs. To assess the function of each phosphorylation site
mutant, expression vectors carrying each coding sequence were
transfected into V3 cells (Fig. 1B). The V3 cell line is DNA-
PKcs deficient and thus is defective in DNA DSB repair (47).
Clones with similar levels of DNA-PKcs expression were se-
lected for each mutant. We next performed cell irradiation
assays for this panel of DNA-PKcs mutants and compared the
radioresistance to that of clones expressing wild-type human
DNA-PKcs as well as to that of an empty vector control clone.
As seen in Fig. 1C, each of the single phosphorylation site
mutant constructs complemented the radiosensitivity of V3
cells similarly to the construct encoding wild-type DNA-PKcs.
In some experiments (four of six) (data not shown), the trans-
fectant expressing mutant C was slightly less radioresistant
than the wild-type transfectant, suggesting that phosphoryla-
tion of Thr2638 is functionally relevant. Indeed, it was found
previously that Thr2638 was a major in vitro phosphorylation
site in DNA-PKcs (9). Recently, Chan et al. (3) reported that
an alanine mutant of Thr2609 (analogous to mutant A) could
only partially complement the radioresistance of V3 cells. In
our studies, the V3 T2609A clone generated displayed a radi-
osensitivity similar to that of transfectants expressing wild-type
DNA-PKcs. Two additional clones expressing mutant A were
also studied, and these clones also displayed radiosensitivity
similar to that of clones expressing wild-type DNA-PKcs (data
not shown). In the report of Chan et al., the single T2609A
mutant V3 transfectant studied showed 10% survival at a dose
of only 2.4 Gy, whereas the wild-type-expressing V3 transfec-
tant showed 10% survival at a dose of 5 Gy. In our studies, the
wild-type transfectant showed 10% survival at an average dose
of 5.28 Gy (range, 4.28 to 6.24), similar to the dose for the
wild-type transfectant studied by Chan et al. The average dose
for 10% survival for the mutant A V3 transfectant was 4.47 Gy
(range, 3.28 to 4.67). The discrepancy in these results is most
likely due to individual clonal variation. In any case, our data
demonstrate that the radioresistance of transfectants express-
ing single phosphorylation site substitutions is not dramatically
different from that of wild-type transfectants. Thus, we con-
clude that phosphorylation of any single site within the cluster
is not essential to DNA-PK’s function in NHEJ.
V3 transfectants expressing DNA-PKcs with multiple phos-
phorylation site mutations are extremely radiosensitive. The
fact that six of seven autophosphorylation sites are tightly clus-
tered within approximately 1% of the total amino acid se-
quence of DNA-PKcs suggested that concurrent phosphoryla-
tion of several sites within the cluster might be functionally
important. Thus, we next generated expression constructs with
two, three, five, or six mutations of serine or threonine to
alanine. These are designated mutants AB, AC, AD, ABCD,
and ABCDE, and they combine the mutations described pre-
viously. Stable cell clones with similar DNA-PKcs expression
levels were selected for each mutant (Fig. 1D), and their radi-
osensitivities were assessed (Fig. 1E). Mutants AB, AC, and
AD only partially complemented the radiosensitive phenotype
of the V3 cells. Significantly, clones expressing DNA-PKcs with
five or six phosphorylation site substitutions (mutants ABCD
TABLE 1. DNA-PKcs with single phosphorylation site mutations,
but not with multiple phosphorylation site mutations, supports
normal levels of V(D)J recombinationa
Transfected plasmidb No. of Amp
r Cmr colonies/
no. of Ampr coloniesc
Recombina-
tion (%)d
pJH290 only 0/46,060 0
0/99,568 0
4/81,634 0.005
pJH290  RAGS 1/30,968 0.003
0/60,270 0
2/72,716 0.003
pJH290  RAGS  wild type 444/35,868 1.24
257/25,520 1.01
203/57,918 0.35
pJH290  RAGS  mut A 283/31,130 0.91
99/38,906 0.25
100/32,928 0.30
pJH290  RAGS  mut B 141/22,540 0.63
120/29,792 0.40
436/42,924 1.02
pJH290  RAGS  mut C 209/22,990 0.91
201/46,354 0.43
53/23,912 0.22
pJH290  RAGS  mut D 107/45,080 0.24
221/40,572 0.54
235/34,888 0.67
pJH290  RAGS  mut E 20/3,300 0.61
136/9,020 1.51
18/5,060 0.36
pJH290  RAGS  mut AB 81/20,384 0.40
138/32,340 0.43
210/23,520 0.89
pJH290  RAGS  mut AC 47/23,520 0.20
60/37,828 0.16
29/32,732 0.09
pJH290  RAGS  mut AD 141/25,450 0.55
58/39,298 0.15
129/41,160 0.31
pJH290  RAGS  mut ABCD 2/5,940 0.03
0/2,900 0
0/2,888 0
pJH290  RAGS  mut ABCDE 5/28,900 0.017
0/21,000 0
1/7,600 0.013
pJH290  RAGS  S/T3D 38/61,800 0.061
22/23,900 0.092
6/14,900 0.040












PJH201  RAGS  mut ABCDE 6/1,200 0.5
9/2,300 0.39
a Transient V(D)J recombination assays were performed as described in Ma-
terials and Methods. RAG expression from plasmid vectors initiates recombina-
tion in V3 cells, as assessed by the plasmid substrate pJH290, which detects
coding joints, or the pJH201 substrate, which detects signal joints, as indicated.
b mut, mutant.
c Numbers from at least three separate experiments are presented.
d Calculated as (number of chloramphenicol-resistant colonies/number of am-
picillin-resistant colonies)  100.
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and ABCDE) displayed radiosensitivities analogous to (or
more severe than) those of the vector-only control clones.
These data demonstrate that concurrent autophosphorylation
of DNA-PKcs on at least two of these clustered sites is a
critical step in DNA damage repair, and they define DNA-
PKcs as a physiologically relevant target of its own protein
kinase activity.
Transiently expressed DNA-PKcs with single but not mul-
tiple phosphorylation site mutations supports wild-type levels
of coding end joining in V3 cells. We next assessed the ability
of the mutant DNA-PKcs to support V(D)J recombination
(Table 1). Wild-type DNA-PKcs substantially complemented
the coding end joining deficit of V3 cells (assessed with sub-
strate pJH290). Similarly, all the mutants, with the exception of
AC, ABCD, and ABCDE, supported near-wild-type levels of
coding joint formation. Mutant AC supported reduced levels
of coding end joining, whereas the abilities of the multiple
phosphorylation mutants ABCD and ABCDE to support
V(D)J recombination were severely impaired. These data are
consistent with reports that minimal function of the NHEJ
pathway can suffice to support V(D)J recombination (21, 39,
49). Thus, only transfectants that are severely impaired in
NHEJ show reduced levels of V(D)J recombination.
Signal end joining is variably depressed in different DNA-
PKcs-deficient cell lines and in different animal models of
DNA-PKcs deficiency (10, 32, 43, 52). The V3 cell line displays
a fairly significant defect in signal end joining (22). This is
evidenced by the fact that wild-type DNA-PKcs increased the
level of signal joints retrieved in transient assays approximately
30-fold (Table 1, pJH201 transfections). In contrast, signal
joining was still impaired in cells transfected with the multisite
mutant ABCDE. We conclude that the multiple phosphoryla-
tion site mutant cannot support normal levels of either signal
or coding end joining during V(D)J recombination.
V3 transfectants expressing DNA-PKcs with multiple phos-
phorylation site mutations display wild-type levels of DNA-PK
activity. DNA-PK activity in extracts derived from V3 trans-
fectants was next assessed by using a previously described
DNA-cellulose pulldown assay (11) and a peptide substrate
(derived from the N terminus of p53). Transfectants expressing
mutant ABCD or ABCDE displayed DNA-PK levels similar to
those of transfectants expressing wild-type DNA-PKcs.
Though DNA-PK activity was consistently somewhat higher in
the transfectant expressing mutant ABCD, this increase might
be explained by the slightly higher DNA-PKcs expression in
the clone analyzed (Fig. 1D). We also utilized recombinant
XRCC4 and Artemis as substrates in pulldown assays; the AB-
CDE mutant phosphorylated XRCC4 and Artemis similarly to
FIG. 2. Transfectants expressing multiple phosphorylation site sub-
stitutions express normal levels of DNA-PK activity. (A) Whole-cell
extracts (500 g) prepared from V3 cells transfected with vector alone,
wild-type DNA-PKcs, mutant ABCD, or mutant ABCDE were assayed
for DNA-PK activity as described in Materials and Methods. Phos-
phorylation of the p53 substrate was assessed after 15, 30, and 120 min
as indicated. Each cell extract was tested in duplicate, and three inde-
pendent extracts were tested for each cell line. Error bars, standard
deviations. (B) Whole-cell extracts (250 g) from V3 cells transfected
with vector alone, wild-type DNA-PKcs, or mutant ABCDE were
assayed for the capacity to phosphorylate no substrate (lanes 1 to 3),
recombinant XRCC4 (lanes 4 to 6), or recombinant Artemis (lanes 7
to 9). (C) DNA-cellulose fractions from 500 g of whole-cell extracts
of V3 cells expressing wild-type DNA-PKcs (lane 1), vector alone (lane
2), or mutant ABCDE (lane 3) were incubated in protein kinase buff-
er with [-32P]ATP. Subsequently, bound proteins were analyzed by
SDS–4% PAGE and autoradiography.
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wild-type DNA-PKcs (Fig. 2B). Finally, by using SDS-PAGE
with a low percentage of acrylamide, a marked reduction in
mobility was observed for highly phosphorylated wild-type
DNA-PKcs. (The indicated phosphoproteins were confirmed
to be DNA-PKcs by immunoblotting [data not shown].) As can
be seen (Fig. 2C), although the ABCDE mutant protein can
still be phosphorylated (possibly at position 3205 outside the
major phosphorylation site cluster or perhaps at another, as yet
unidentified site) hyperphosphorylation of the mutant protein
(as evidenced by a gel shift) was not observed. In summary,
DNA-PKcs containing multiple autophosphorylation site mu-
tations is active toward exogenous substrates such as a syn-
thetic peptide, XRCC4, and Artemis; therefore, the radiosen-
sitive phenotype of cells expressing mutant ABCDE is not due
to a lack of protein kinase activity per se.
DNA-PK complexes containing wild-type or ABCDE mutant
DNA-PKcs display similar stabilities. To begin to assess the
biochemical basis of defective NHEJ in cells expressing the
ABCDE mutant, we purified the wild-type and ABCDE mu-
tant proteins from the V3 transfectants (see Materials and
Methods) (Fig. 3A). We have shown previously using purified
proteins that autophosphorylation of DNA-PKcs results in disso-
ciation of DNA-PKcs from Ku bound to DNA and loss of kinase
activity. Thus, we tested whether preautophosphorylation of the
mutant protein could affect kinase activity. Although the mutant
protein is slightly more resistant to preautophosphorylation,
preautophosphorylated DNA-PK complexes containing either
wild-type or mutant DNA-PKcs have dramatically lower protein
kinase activity than nonphosphorylated DNA-PK (Fig. 3B). The
modest difference in resistance to autophosphorylation likely ex-
plains the variance in protein kinase activity observed over time
with the mutant versus wild-type proteins without preautophos-
phorylation. Still, these data suggest that phosphorylation at ad-
ditional sites facilitates kinase disassembly.
To more formally assess complex stability after autophos-
phorylation, a modified EMSA was also performed. Samples
were prepared for analysis in two steps. First, complexes
were allowed to assemble onto the DNA probe by using ei-
ther wortmannin-inactivated DNA-PKcs or non-wortmannin-
treated DNA-PKcs in the presence of ATP to allow autophos-
phorylation. After kinase activity was stopped (by the addition
of EDTA), the relative stabilities of the complexes were probed
by a second incubation in increasing NaCl concentrations. As
can be seen (Fig. 3C), under more stringent conditions, neither
autophosphorylated wild-type nor autophosphorylated AB-
CDE mutant DNA-PKcs forms stable complexes with Ku-
FIG. 3. Autophosphorylation within the 2609-to-2647 cluster is not required for autophosphorylation-induced kinase dissociation. (A) Wild-
type and ABCDE mutant DNA-PKcs’s were purified as described in Materials and Methods. Coomassie-stained SDS-PAGE gel shows analysis
of fractions from a purification of the recombinant ABCDE mutant of DNA-PKcs. Lane 1, 10 g of clarified extract from V3 cells expressing the
ABCDE mutant; lane 2, 10 g of flowthrough after the extract was loaded onto an affinity column coupled with a peptide from the C terminus
of Ku80 (80peptide); lane 3, 2 g of pooled fractions containing DNA-PKcs from 80peptide eluate; lane 4, 2 g of flowthrough of Mono S column;
lane 5, 2 g of pooled DNA-PKcs-containing fractions from Mono S; lane 6, 2 g of purified DNA-PKcs from placenta. Asterisk indicates location
of major contaminant in eluate from 80peptide column. Similar results were obtained by purifying recombinant wild-type DNA-PKcs. (B) Kinase
activities of purified wild-type and ABCDE mutant DNA-PKcs’s were assessed as described in Materials and Methods. DNA-protein complexes
were preformed by incubation (at 30°C for 10 min) of 1 nM purified recombinant Ku, 1 nM either purified wild-type (wt) or purified ABCDE
mutant DNA-PKcs, and 10 g of sheared calf thymus DNA/ml. Reactions were started by transfer to 37°C and addition of 400 M peptide
substrate, 200 M [-32P]ATP (0.5 Ci/mmol), and 5 mM MgCl2. The impact of prior autophosphorylation (pre-autophos.) was assessed in parallel
reactions by including the same concentrations of ATP and MgCl2 in the preincubation step as well. (C) The stabilities of DNA-PK complexes
containing wild-type or mutant DNA-PKcs were assessed by EMSA as described in Materials and Methods. DNA-protein complexes were formed
with a 60-bp radiolabeled duplex, Ku, and wt or ABCDE mutant (m) DNA-PKcs as indicated. Complexes were preincubated at 75 mM salt by using
either mock-treated DNA-PKcs, active kinase ( Auto-phos.), or wortmannin-inactivated kinase ( Auto-phos.). Autophosphorylation was
arrested by addition of 5 mM EDTA. Reactions were then adjusted to the indicated salt concentrations and incubated for a further 10 min at room
temperature before surviving DNA-protein complexes were fixed by cross-linking with 0.25% glutaraldehyde. DNA-protein complexes were
resolved by electrophoresis on a 3.5% native polyacrylamide gel.
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bound DNA, although complexes containing the mutant
protein are consistently slightly more stable than wild-type
complexes. These data suggest that further autophosphoryla-
tion is required for kinase disassembly.
An ABCDE mutant with aspartic acid substitutions is par-
tially competent in NHEJ. The data presented above suggest
that autophosphorylation outside of the major cluster might be
important to signal kinase inactivation, at least in vitro. In an
attempt to mimic constitutively phosphorylated DNA-PKcs in
living cells, we next constructed an expression vector with as-
partic acid substitutions for each of these six phosphorylation
sites within the major cluster. We considered two possibilities.
If phosphorylation within the major cluster induces release of
DNA-PKcs from Ku bound to DNA, then the S/T3D-substi-
tuted DNA-PKcs should not be able to associate at all with Ku
bound to DNA ends. In this case the mutant protein should not
complement the NHEJ defect in V3 cells, and we would expect
to observe reduced kinase activity in extracts from these cells.
Another possibility is that autophosphorylation within the ma-
jor cluster is important for another reason, perhaps by inducing
some conformational change in the repair complex that facil-
itates subsequent steps in the repair process. In this case, the
mutant protein should at least partially complement the NHEJ
deficit in V3 cells, and we would expect the mutant protein to
be an active protein kinase.
The expression vector with aspartic acid substitutions at
ABCDE (designated S/T3D) was transfected into the V3 cell
line, and two cell clones with similar DNA-PKcs expression
levels were studied (Fig. 4A). DNA-PK activity was assessed
using the DNA-cellulose pulldown assay and the p53 peptide
substrate. Transfectants expressing the S/T3A mutant dis-
played DNA-PK levels similar to those of transfectants ex-
pressing wild-type DNA-PKcs or the ABCDE mutant (Fig.
4B). As can be seen in Fig. 4C, although cells expressing the
S/T3D mutant are still very radiosensitive compared to cells
expressing wild-type DNA-PKcs, these cells are slightly more
radioresistant than the vector-only control and significantly
more radioresistant than the ABCDE mutant. Similarly, cod-
ing end resolution was slightly better in transient transfections
comparing the S/T3D mutant to the ABCDE mutant (Table
1). We attribute this weak partial phenotype to poor mimicking
of phosphoserine or phosphothreonine by the aspartic acid
substitutions, although other explanations are also possible.
Still, these data are consistent with a model whereby phosphor-
ylation within the major cluster induces a conformational
change that is requisite for subsequent steps in DNA end
joining.
Autophosphorylation within the 2609-to-2647 cluster is not
required for the interaction of DNA-PKcs with Artemis or to
facilitate opening of coding end hairpins. The recent elegant
studies of Ma et al. demonstrated that DNA-PKcs interacts
with Artemis to generate an active DNA end-processing com-
plex (31). To assess whether autophosphorylation within the
2609-to-2647 cluster is required for the interaction of Artemis
with DNA-PKcs, a baculovirus vector expressing V5-His-
tagged Artemis was constructed. Although only a fraction of
the baculovirus-expressed, V5-His-tagged Artemis was soluble
(Fig. 5A), a significant portion of the soluble protein fraction-
ated onto Ni agarose beads. Extracts from V3 transfectants
expressing either wild-type DNA-PKcs or the DNA-PKcs mu-
tant ABCD were incubated with extracts from Artemis-in-
fected Sf9 cells or extracts from control Sf9 cells and then
absorbed onto Ni agarose. Wild-type DNA-PKcs and the
multiple phosphorylation site mutant copurified equivalently
with Ni agarose-immobilized Artemis (Fig. 5A, lanes 11 and
12), suggesting that autophosphorylation within the major
phosphorylation site cluster is not required for the interaction
of DNA-PKcs with Artemis.
Ma et al. also demonstrated that the DNA-PKcs–Artemis
complex opens hairpinned DNA ends (like the ones that result
from RAG-mediated cleavage) and that DNA-PK’s kinase ac-
tivity is requisite for this activity. However, it was not deter-
mined whether DNA-PK’s phosphorylation of Artemis or
phosphorylation of DNA-PKcs itself is important for activating
the hairpin nuclease. Thus, we next assessed broken DNA
intermediates generated during transient V(D)J assays by us-
FIG. 4. An ABCDE mutant with aspartic acid substitutions is partially competent in NHEJ. (A) Immunoblot analyses of whole-cell extracts
from V3 transfectants expressing wild-type (wt) DNA-PKcs (lane 1), vector alone (lane 2), mutant ABCDE (lane 3), the ST3D mutant (clone 5),
(lane 4), and the ST3D mutant (clone 11) (lane 5). (B) Whole-cell extracts (500 g) prepared from V3 cells transfected with either vector alone,
wt DNA-PKcs, mutant ABCDE, or one of two independent clones (clones 5 and 11) expressing the ST3D mutation were assayed for DNA-PK
activity. Phosphorylation of the p53 substrate was assessed after 60 min. Each cell extract was tested in duplicate, and three independent extracts
were tested for each cell line. Error bars, standard deviations. (C) Radiation resistance of V3 transfectants expressing wt DNA-PKcs, vector alone,
mutant ABCDE, or the ST3D mutant. Data are presented as percent survival relative to that of nonirradiated controls (set at 100%). Error bars,
standard errors of the means of three separate experiments.
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ing an LMPCR assay (Fig. 5B). Signal ends were detected by
using a blunt-ended oligonucleotide in the ligation step. As
expected, blunt signal ends are readily detected from Hirt
supernatants prepared from cells transfected with RAG ex-
pression constructs in the presence or absence of DNA-PKcs
expression. Previous studies have suggested that hairpin open-
ing likely occurs 2 bp from the hairpinned termini, leaving a
4-bp 3 overhang (31). Thus, to detect opened hairpin coding
termini, an oligonucleotide with a 4-bp 3 overhang, comple-
mentary to a hairpin opened 2 bp from the tip of the pJH290
substrate, was utilized in the ligation step. No opened coding
end intermediates were detected in transfections with substrate
alone or from transfections including substrate plus the RAG
proteins (Fig. 5B, lanes 6 and 7). This is consistent with pre-
vious studies demonstrating that hairpinned termini in DNA-
PKcs-deficient cells remain sealed (41, 53). In contrast, opened
coding ends were detected in transfectants including either
wild-type DNA-PKcs or the ABCDE mutant (Fig. 5B, lanes 8
and 9). Thus, we conclude that the ABCDE mutant is fully
capable of activating the hairpin-opening activity of Artemis.
Coding joints mediated by mutant ABCDE have minimal
nucleotide loss from joined coding ends. Structural analyses of
signal and coding joints as well as recombination intermediates
has provided significant insight into the mechanistic details of
both V(D)J recombination and NHEJ. Thus, we next se-
quenced rare coding joints mediated by the ABCDE mutant
isolated from transient V(D)J recombination assays and com-
pared them to sequences obtained from transfections including
wild-type DNA-PKcs. As expected, coding joints obtained
from recombination assays including wild-type DNA-PKcs
yielded a diverse collection of sequences (Fig. 6; Table 2).
Nucleotide loss from each joint ranged from 0 to 14 nucleo-
tides, with an average of 4.61 bp lost per joint. Of the joints
with at least one complete coding end (37 of 122 [30%]), P
segments were apparent in 10 of 37 (27%). Short sequence
homologies of 1 to 2 bp could be observed in 44% of the joints.
FIG. 5. Autophosphorylation within the 2609-to-2647 cluster is not required for the interaction of DNA-PKcs with Artemis or to facilitate
opening of coding end hairpins. (A) (Left) SDS-PAGE analyses of the following fractions of Sf9 cells infected with a baculovirus encoding an
Artemis-V5 His-tagged fusion protein: precleared whole-cell lysate (lane 1) and cleared lysate (lane 2). Marker, marker proteins, with molecular
weights (in thousands) given on the left. (Right) Western blot of whole-cell extracts or Ni-agarose fractions. Lanes 4 to 6, whole-cell extracts of
V3 cells transfected with vector alone (lane 4), wild-type DNA-PKcs (lane 5), or mutant ABCD (lane 6); lanes 7 to 9, Ni-agarose fractions of
control Sf9 extracts coincubated with extracts from V3 cells transfected with vector alone (lane 7), wild-type DNA-PKcs (lane 8), or mutant ABCD
(lane 9); lanes 10 to 12, Ni-agarose fractions of extracts from Sf9 cells expressing Artemis coincubated with extracts from V3 cells transfected with
vector alone (lane 10), wild-type DNA-PKcs (lane 11), or mutant ABCD (lane 12). (B) LMPCR was performed on Hirt supernatants prepared
from V3 cells transiently transfected with substrate alone (lanes 1 and 6), substrate and RAG expression vectors (lanes 2 and 7), substrate plus
RAG and wild-type DNA-PKcs expression vectors (lanes 3 and 8), or substrate plus RAG and mutant ABCDE expression vectors (lanes 4 and
9). Lanes 5 and 10 included no input DNA in the LMPCRs. In lanes 1 to 5, a blunt oligonucleotide was ligated to Hirt fractions, and PCR
amplifications to detect signal ends were performed. In lanes 6 to 10, an oligonucleotide with a 4-bp overhang complementary to a potential opened
coding end in substrate pJH290 was ligated to Hirt fractions, and PCR amplifications to detect coding ends were performed.
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FIG. 6. Coding joints mediated by mutant ABCDE have minimal nucleotide loss from joined ends. The sequences of coding ends as they occur
in the pJH290 substrate are shown above the sequences of the recombinant junctions. The number of observations of each sequence is given in
parentheses to the right of the sequence. All duplicate sequences were derived from separate transfections. Nucleotides in columns headed by “p”
are palindromic nucleotides added to each junction. Nucleotides that cannot be unequivocally assigned to a particular coding end are underlined
and listed in the 5-most location. Portions of the wild-type (WT) and RAG-only coding joints are from references 21 and 49.
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Though only a few rare coding joints were sequenced from
transfections with no DNA-PKcs, structurally these were con-
sistent with classic SCID joints. These joints display excessive
nucleotide loss and a high incidence of long P segments when
a coding end is complete (12 of 13 [92%]).
The most obvious difference between joints isolated from
transfections with wild-type DNA-PKcs versus the ABCDE
mutant is that there is remarkably less nucleotide loss at the
site of joining in joints mediated by the mutant protein. Nu-
cleotide loss from each joint ranged from 0 to 7 nucleotides,
with an average of only 1.43 bp lost per joint. Furthermore,
70% of the coding ends (39 of 56) had no nucleotide loss versus
only 30% (37 of 122) for joints mediated by wild-type DNA-
PKcs. Of the joints with at least one complete coding end, P
segments were apparent in 10 of 40 (25%). This is completely
analogous to P segment incidence in joints mediated by wild-
type DNA-PKcs and substantiates our conclusion that hairpin
opening is normal in joints mediated by mutant ABCDE. Al-
though four P segments were slightly longer than the normal 2
bp, slightly longer P segments were also occasionally observed
in wild-type joints. Remarkably, short sequence homology at
the junctures could not be observed in any of the 28 coding
sequences, suggesting that this mechanism to facilitate end
joining might be blocked in cells expressing the ABCDE mu-
tant (although this may be partially attributed to the lower
extent of base loss in these joints).
We also sequenced 25 coding joints mediated by the S/T3D
mutant protein. These joints more closely resembled those
mediated by wild-type DNA-PKcs: they averaged 3.08 bp lost
per joint, and 19 of 50 coding ends (38%) were complete. Of
the joints with at least one complete coding end, 5 of 19 (26%)
had a P element, again analogous to P segment incidence in
joints mediated by either wild-type DNA-PKcs or mutant
ABCDE. Finally, short sequence homologies of 1 to 2 bp were
apparent in 52% of the joints, also similar to the percentage in
joints mediated by wild-type DNA-PKcs. In summary, these
data suggest that end processing during V(D)J recombination
is in some way impeded in the presence of the ABCDE mutant.
We suggest that phosphorylation within the major cluster in-
duces a conformational change that facilitates DNA end align-
ment and/or end processing prior to end joining.
DISCUSSION
DNA-PK has been vigorously studied for more than a de-
cade, and numerous potential substrates have been reported.
In fact, more than 40 different proteins have been shown to be
efficient in vitro targets of DNA-PK. To date, DNA-PKcs itself
is the only unequivocally defined, functionally relevant target
of its own kinase activity (3, 44).
Numerous spontaneous and targeted mutations of DNA-
PKcs have been studied previously. These include three spon-
taneous germ line mutations (30, 32, 48), five spontaneous
mutations in cultured cell lines (26, 52), four targeted germline
mutations (2, 12, 23, 45), and three reports of specific targeted
mutations of DNA-PKcs expressed ectopically in cultured cells
(21, 22, 49). In each of these, loss of DNA-PKcs function in
vivo was associated with loss of DNA-PK activity. The mul-
tiphosphorylation site DNA-PKcs mutants are the first DNA-
PKcs mutants that retain protein kinase activity but are inca-
pable of supporting NHEJ. Thus, these mutants may be helpful
in discerning other postulated functions (i.e., apart from
NHEJ) of DNA-PKcs (16, 42).
We have explored several possible molecular mechanisms
that could account for the radiosensitive phenotype of cells
expressing the multisite autophosphorylation mutants of
DNA-PKcs. Mutations in the autophosphorylation sites do not
affect the in vitro protein kinase activity of DNA-PK, as judged
by the ability of extracts from V3 cells containing DNA-PKcs
with multiple autophosphorylation site mutations to phosphor-
ylate synthetic peptide substrates, recombinant XRCC4, or
recombinant Artemis. This suggests that the radiosensitive
phenotype is due not to a lack of DNA-PK activity but rather
is a consequence of the inability of DNA-PKcs to undergo
autophosphorylation.
Similarly, mutations in the autophosphorylation sites of
DNA-PKcs do not affect the ability of DNA-PKcs to interact
with or activate Artemis. In fact, if lack of Artemis activation
were the only important deficit in cells expressing mutant
ABCDE, one might expect complementation of V3’s signal
joint deficit by mutant ABCDE, since Artemis is not required
for signal end joining (35, 40). This is not the case. In sum,
these data demonstrate that the function of DNA-PKcs in
NHEJ goes beyond its role in activating the Artemis endonu-
clease. This is consistent with conclusions of a recent report
directly comparing mice with targeted deletions of Artemis and
DNA-PKcs (40).
The most revealing data as to the functional block of the
multi-phosphorylation site mutants are the sequence analyses
of coding joints mediated by the mutants. These joints have
minimal nucleotide loss from rarely joined coding ends. Fur-
thermore, there is no evidence of joining via short sequence
homologies, a mechanism commonly observed in joints medi-
ated by wild-type DNA-PKcs. These data imply that autophos-
phorylation of DNA-PKcs facilitates alignment via short se-











(no. of P segments/
no. complete ends)
Wild type 61 4.61 30 (37/122) 44 (27/61) 27 (10/37)
ABCDE 28 1.43 70 (39/56) 0 (0/27) 25 (10/40)
S/T3D 25 3.08 38 (19/50) 52 (13/25) 26 (5/19)
RAGS only 16 14.69 41 (13/32) 31 (5/16) 92 (12/13)
a Average nucleotide loss per joint, percent intact coding ends, percent sequences with short sequence homologies, and percent P segments per full-length end were
calculated from sequences presented in Fig. 6.
b SSH, short sequence homologies.
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quence homologies and/or facilitates access of the DNA ends
to DNA end-processing factors, perhaps including the endo-
nuclease activity of Artemis and a DNA polymerase (31). We
have preliminary data suggesting that the 3 hydroxyls of the
DNA break are not completely occluded by nonphosphory-
lated DNA-PKcs. Briefly, these data show that in transient
recombination assays including an expression vector encoding
Tdt, Tdt can add N segments to rare coding ends in the pres-
ence of the ABCDE mutant (data not shown).
Several studies have shown that DNA-PKcs facilitates align-
ment or synapses of DNA-PK-bound DNA ends (7, 33, 50).
Furthermore, a recent report suggests that synapses of the two
end binding complexes are required for kinase activation (7).
Based on this report, it seems likely that mutant ABCDE forms
synapses normally, since the kinase activity of the mutant pro-
tein is indistinguishable from that of wild-type DNA-PKcs.
Chu and colleagues have proposed a model whereby DNA-
PKcs may promote melting and alignment of DNA ends in a
synaptic complex of two DNA-PK-bound DNA ends (17, 27).
One attractive possibility is that autophosphorylation is re-
quired for this potential function of DNA-PKcs.
In summary, our results showing that autophosphorylation
of DNA-PKcs between residues 2609 and 2647 is required
during NHEJ lead us to favor a model whereby autophosphor-
ylation induces a conformational change that leads to remod-
eling of the DNA-PK complex. Furthermore, this conforma-
tional change in DNA-PKcs is requisite for efficient end
processing and DNA repair.
ACKNOWLEDGMENTS
This work was supported by Public Health Service grants AI32600,
AI42938 (to K.M.), and CA 84442-01 (to D.A.R.) from the National
Institutes of Health. Work in the laboratory of S.P.L.-M. is supported
by the Alberta Heritage Foundation for Medical Research and the
Canadian Institutes for Health Research.
REFERENCES
1. Baumann, P., and S. C. West. 1998. DNA end-joining catalyzed by human
cell-free extracts. Proc. Natl. Acad. Sci. USA 95:14066–14070.
2. Bogue, M. A., C. Jhappan, and D. B. Roth. 1998. Analysis of variable
(diversity) joining recombination in DNA-dependent protein kinase (DNA-
PK)-deficient mice reveals DNA-PK-independent pathways for both signal
and coding joint formation. Proc. Natl. Acad. Sci. USA 95:15559–15564.
3. Chan, D. W., B. P. Chen, S. Prithivirajsingh, A. Kurimasa, M. D. Story, J.
Qin, and D. J. Chen. 2002. Autophosphorylation of the DNA-dependent
protein kinase catalytic subunit is required for rejoining of DNA double-
strand breaks. Genes Dev. 16:2333–2338.
4. Chan, D. W., and S. P. Lees-Miller. 1996. The DNA-dependent protein
kinase is inactivated by autophosphorylation of the catalytic subunit. J. Biol.
Chem. 271:8936–8941.
5. Chan, D. W., R. Ye, C. J. Veillette, and S. P. Lees-Miller. 1999. DNA-
dependent protein kinase phosphorylation sites in Ku 70/80 heterodimer.
Biochemistry 38:1819–1828.
6. Critchlow, S. E., and S. P. Jackson. 1998. DNA end-joining: from yeast to
man. Trends Biochem. Sci. 23:394–398.
7. DeFazio, L. G., R. M. Stansel, J. D. Griffith, and G. Chu. 2002. Synapsis of
DNA ends by DNA-dependent protein kinase. EMBO J. 21:3192–3200.
8. Douglas, P., G. B. Moorhead, R. Ye, and S. P. Lees-Miller. 2001. Protein
phosphatases regulate DNA-dependent protein kinase activity. J. Biol.
Chem. 276:18992–18998.
9. Douglas, P., G. P. Sapkota, N. Morrice, Y. Yu, A. A. Goodarzi, D. Merkle, K.
Meek, D. R. Alessi, and S. P. Lees-Miller. 2002. Identification of in vitro and
in vivo phosphorylation sites in the catalytic subunit of the DNA-dependent
protein kinase. Biochem. J. 368:243–251.
10. Errami, A., D. M. He, A. A. Friedl, W. J. Overkamp, B. Morolli, E. A.
Hendrickson, F. Eckardt-Schupp, M. Oshimura, P. H. Lohman, S. P. Jack-
son, and M. Z. Zdzienicka. 1998. XR-C1, a new CHO cell mutant which is
defective in DNA-PKcs, is impaired in both V(D)J coding and signal joint
formation. Nucleic Acids Res. 26:3146–3153.
11. Finnie, N. J., T. M. Gottlieb, T. Blunt, P. A. Jeggo, and S. P. Jackson. 1995.
DNA-dependent protein kinase activity is absent in xrs-6 cells: implications
for site-specific recombination and DNA double-strand break repair. Proc.
Natl. Acad. Sci. USA 92:320–324.
12. Gao, Y., J. Chaudhuri, C. Zhu, L. Davidson, D. T. Weaver, and F. W. Alt.
1998. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent
functions for KU in V(D)J recombination. Immunity 9:367–376.
13. Gell, D., and S. P. Jackson. 1999. Mapping of protein-protein interactions
within the DNA-dependent protein kinase complex. Nucleic Acids Res.
27:3494–3502.
14. Gellert, M. 2002. V(D)J recombination: rag proteins, repair factors, and
regulation. Annu. Rev. Biochem. 71:101–132.
15. Grawunder, U., M. Wilm, X. Wu, P. Kulesza, T. E. Wilson, M. Mann, and
M. R. Lieber. 1997. Activity of DNA ligase IV stimulated by complex for-
mation with XRCC4 protein in mammalian cells. Nature 388:492–495.
16. Gurley, K. E., and C. J. Kemp. 2001. Synthetic lethality between mutation in
Atm and DNA-PK(cs) during murine embryogenesis. Curr. Biol. 11:191–
194.
17. Hammarsten, O., L. G. DeFazio, and G. Chu. 2000. Activation of DNA-
dependent protein kinase by single-stranded DNA ends. J. Biol. Chem.
275:1541–1550.
18. Hartley, K. O., D. Gell, G. C. Smith, H. Zhang, N. Divecha, M. A. Connelly,
A. Admon, S. P. Lees-Miller, C. W. Anderson, and S. P. Jackson. 1995.
DNA-dependent protein kinase catalytic subunit: a relative of phosphatidyl-
inositol 3-kinase and the ataxia telangiectasia gene product. Cell 82:849–856.
19. Jackson, S. P. 1997. DNA-dependent protein kinase. Int. J. Biochem. Cell
Biol. 29:935–938.
20. Jeggo, P. A. 1998. DNA breakage and repair. Adv. Genet. 38:185–218.
21. Kienker, L. J., E. K. Shin, and K. Meek. 2000. Both V(D)J recombination
and radioresistance require DNA-PK kinase activity, though minimal levels
suffice for V(D)J recombination. Nucleic Acids Res. 28:2752–2761.
22. Kurimasa, A., S. Kumano, N. V. Boubnov, M. D. Story, C. S. Tung, S. R.
Peterson, and D. J. Chen. 1999. Requirement for the kinase activity of
human DNA-dependent protein kinase catalytic subunit in DNA strand
break rejoining. Mol. Cell. Biol. 19:3877–3884.
23. Kurimasa, A., H. Ouyang, L. Dong, S. Wang, X. Li, C. Cordon-Cardo, D. J.
Chen, and G. C. Li. 1999. Catalytic subunit of DNA-dependent protein
kinase: impact on lymphocyte development and tumorigenesis. Proc. Natl.
Acad. Sci. USA 96:1403–1408.
24. Leber, R., T. W. Wise, R. Mizuta, and K. Meek. 1998. The XRCC4 gene
product is a target for, and interacts with the DNA dependent protein kinase.
J. Biol. Chem. 273:1794–1801.
25. Lees-Miller, S. P. 1996. The DNA-dependent protein kinase, DNA-PK: 10
years and no ends in sight. Biochem. Cell. Biol. 74:503–512.
26. Lees-Miller, S. P., R. Godbout, D. W. Chan, M. Weinfeld, R. S. Day, G. M.
Barron, and J. Allalunis-Turner. 1995. Absence of p350 subunit of DNA-
activated protein kinase from a radiosensitive human cell line. Science 267:
1183–1185.
27. Leuther, K. K., O. Hammarsten, R. D. Kornberg, and G. Chu. 1999. Struc-
ture of DNA-dependent protein kinase: implications for its regulation by
DNA. EMBO J. 18:1114–1123.
28. Li, Z., T. Otevrel, Y. Gao, H. L. Cheng, B. Seed, T. D. Stamato, G. E. Taccioli,
and F. W. Alt. 1995. The XRCC4 gene encodes a novel protein involved in
DNA double-strand break repair and V(D)J. recombination. Cell 83:1079–
1089.
29. Lieber, M. R. 1999. The biochemistry and biological significance of nonho-
mologous DNA end joining: an essential repair process in multicellular
eukaryotes. Genes Cells 4:77–85.
30. Lieber, M. R., J. E. Hesse, S. Lewis, G. C. Bosma, N. Rosenberg, K. Mizuu-
chi, M. J. Bosma, and M. Gellert. 1989. Abnormal V(D)J recombination in
murine severe combined immune deficiency: absence of coding joints and
formation of alternative products. Curr. Top. Microbiol. Immunol. 152:69–
75.
31. Ma, Y., U. Pannicke, K. Schwarz, and M. R. Lieber. 2002. Hairpin opening
and overhang processing by an Artemis/DNA-dependent protein kinase
complex in nonhomologous end joining and V(D)J recombination. Cell
108:781–794.
32. Meek, K., L. Kienker, C. Dallas, W. Wang, M. J. Dark, P. J. Venta, M. L.
Huie, R. Hirschhorn, and T. Bell. 2001. SCID in Jack Russell terriers: a new
animal model of DNA-PKcs deficiency. J. Immunol. 167:2142–2150.
33. Merkle, D., P. Douglas, G. B. Moorhead, Z. Leonenko, Y. Yu, D. Cramb,
D. P. Bazett-Jones, and S. P. Lees-Miller. 2002. The DNA-dependent pro-
tein kinase interacts with DNA to form a protein-DNA complex that is
disrupted by phosphorylation. Biochemistry 41:12706–12714.
34. Modesti, M., J. E. Hesse, and M. Gellert. 1999. DNA binding of Xrcc4
protein is associated with V(D)J recombination but not with stimulation of
DNA ligase IV activity. EMBO J. 18:2008–2018.
35. Moshous, D., I. Callebaut, R. de Chasseval, B. Corneo, M. Cavazzana-Calvo,
F. Le Deist, I. Tezcan, O. Sanal, Y. Bertrand, N. Philippe, A. Fischer, and
J. P. de Villartay. 2001. Artemis, a novel DNA double-strand break repair/
V(D)J recombination protein, is mutated in human severe combined im-
mune deficiency. Cell 105:177–186.
VOL. 23, 2003 DNA-PKcs AUTOPHOSPHORYLATION IS REQUIRED FOR NHEJ 5847
36. Nick McElhinny, S. A., C. M. Snowden, J. McCarville, and D. A. Ramsden.
2000. Ku recruits the XRCC4-ligase IV complex to DNA ends. Mol. Cell.
Biol. 20:2996–3003.
37. Pastink, A., J. C. Eeken, and P. H. Lohman. 2001. Genomic integrity and the
repair of double-strand DNA breaks. Mutat. Res. 480–481:37–50.
38. Pierce, A. J., J. M. Stark, F. D. Araujo, M. E. Moynahan, M. Berwick, and
M. Jasin. 2001. Double-strand breaks and tumorigenesis. Trends Cell. Biol.
11:52–59.
39. Riballo, E., S. E. Critchlow, S. H. Teo, A. J. Doherty, A. Priestley, B. Brough-
ton, B. Kysela, H. Beamish, N. Plowman, C. F. Arlett, A. R. Lehmann, S. P.
Jackson, and P. A. Jeggo. 1999. Identification of a defect in DNA ligase IV
in a radiosensitive leukaemia patient. Curr. Biol. 9:699–702.
40. Rooney, S., J. Sekiguchi, C. Zhu, H. L. Cheng, J. Manis, S. Whitlow, J.
DeVido, D. Foy, J. Chaudhuri, D. Lombard, and F. W. Alt. 2002. Leaky scid
phenotype associated with defective V(D)J coding end processing in artemis-
deficient mice. Mol. Cell 10:1379–1390.
41. Roth, D. B., J. P. Menetski, P. B. Nakajima, M. J. Bosma, and M. Gellert.
1992. V(D)J recombination: broken DNA molecules with covalently sealed
(hairpin) coding ends in scid mouse thymocytes. Cell 70:983–991.
42. Sekiguchi, J., D. O. Ferguson, H. T. Chen, E. M. Yang, J. Earle, K. Frank,
S. Whitlow, Y. Gu, Y. Xu, A. Nussenzweig, and F. W. Alt. 2001. Genetic
interactions between ATM and the nonhomologous end-joining factors in
genomic stability and development. Proc. Natl. Acad. Sci. USA 98:3243–
3248.
43. Shin, E. K., T. Rijkers, A. Pastink, and K. Meek. 2000. Analyses of TCRB
rearrangements substantiate a profound deficit in recombination signal se-
quence joining in SCID foals: implications for the role of DNA-dependent
protein kinase in V(D)J recombination. J. Immunol. 164:1416–1424.
44. Soubeyrand, S., L. Pope, B. Pakuts, and R. J. Hache. 2003. Threonines
2638/2647 in DNA-PK are essential for cellular resistance to ionizing radi-
ation. Cancer Res. 63:1198–1201.
45. Taccioli, G. E., A. G. Amatucci, H. J. Beamish, D. Gell, X. H. Xiang, M. I. T.
Arzayus, A. Priestley, S. P. Jackson, A. M. Rothstein, P. A. Jeggo, and
V. L. M. Herrera. 1998. Targeted disruption of the catalytic subunit of the
DNA-PK gene in mice confers severe combined immunodeficiency and
radiosensitivity. Immunity 9:355–366.
46. Walker, J. R., R. A. Corpina, and J. Goldberg. 2001. Structure of the Ku
heterodimer bound to DNA and its implications for double-strand break
repair. Nature 412:607–614.
47. Whitmore, G. F., A. J. Varghese, and S. Gulyas. 1989. Cell cycle responses of
two X-ray sensitive mutants defective in DNA repair. Int. J. Radiat. Biol.
56:657–665.
48. Wiler, R., R. Leber, B. B. Moore, L. F. VanDyk, L. E. Perryman, and K.
Meek. 1995. Equine severe combined immunodeficiency: a defect in V(D)J
recombination and DNA-dependent protein kinase activity. Proc. Natl.
Acad. Sci. USA 92:11485–11489.
49. Woods, T., W. Wang, E. Convery, A. Errami, M. Z. Zdzienicka, and K. Meek.
2002. A single amino acid substitution in DNA-PKcs explains the novel
phenotype of the CHO mutant, XR-C2. Nucleic Acids Res. 30:5120–5128.
50. Yaneva, M., T. Kowalewski, and M. R. Lieber. 1997. Interaction of DNA-
dependent protein kinase with DNA and with Ku: biochemical and atomic-
force microscopy studies. EMBO J. 16:5098–5112.
51. Yoo, S., and W. S. Dynan. 1999. Geometry of a complex formed by double
strand break repair proteins at a single DNA end: recruitment of DNA-PKcs
induces inward translocation of Ku protein. Nucleic Acids Res. 27:4679–
4686.
52. Zdzienicka, M. 1999. Mammalian X-ray-sensitive mutants which are defec-
tive in non-homologous (illegitimate) DNA double-strand break repair. Bio-
chimie 81:107–116.
53. Zhu, C., and D. B. Roth. 1995. Characterization of coding ends in thymocytes
of scid mice: implications for the mechanism of V(D)J recombination. Im-
munity 2:101–112.
5848 DING ET AL. MOL. CELL. BIOL.
